Taxane Therapy
Taxane Therapy is a chemotherapeutic approach that belongs to the class of antimitotic agents, distinguished by its specific mechanism of action involving the stabilization of microtubules to inhibit cellular division in proliferating cancer cells.
1.2K
Publications
65.7K
Citations
8.2K
Authors
2K
Institutions
Publications per year
2017–2026
317
1.2K
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
Mansoor R. Mirza, Bradley J. Monk, Jørn Herrstedt et al. · New England Journal of Medicine · 2016 · 2.5K citations · Full text
Medicine, Oncology, Pharmacotherapy +15
S. Loibl, Michael Untch, Nicole Burchardi et al. · Annals of Oncology · 2019 · 694 citations
Medicine, Oncology, Pharmacology +16
1–5 of 1.2K
8.2K
15
h-index
13
h-index
13
h-index
11
h-index
11
h-index
1–5 of 8.2K
2K
The University of Texas MD Anderson Cancer Center
Houston, United States
28 h-index
305 publications
40K citations
Memorial Sloan Kettering Cancer Center
New York, United States
27 h-index
163 publications
27.6K citations

Cornell University
Ithaca, United States
26 h-index
235 publications
26.3K citations
Dana-Farber Cancer Institute
Boston, United States
21 h-index
113 publications
15.9K citations

Johns Hopkins University
Baltimore, United States
17 h-index
116 publications
12.5K citations
Bristol-Myers Squibb (United States)
New York, United States
17 h-index
121 publications
5.5K citations
University of North Carolina at Chapel Hill
Chapel Hill, United States
17 h-index
74 publications
6.5K citations

Institut Gustave Roussy
Villejuif, France
17 h-index
64 publications
2.9K citations
1–8 of 2K
144 publications · 10.6K citations
50
h-index
Repository · 102 publications · 5.6K citations
41
h-index
38 publications · 3K citations
29
h-index
42 publications · 2.1K citations
26
h-index
BJC · 25 publications · 1.2K citations
21
h-index
1–5